Emerging research indicates that retatrutide, a dual-action medication, could significantly impact the approach of excess weight . Unlike many existing weight loss solutions, retatrutide works as both a GLP-1 receptor and a GIP receiver , affecting multiple pathways involved in appetite regulation and glucose optimization. Initial patient studies